HCA Healthcare, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed on February 24, 2025, covering events occurring on February 18 and February 19, 2025. The filing pertains to HCA Healthcare, Inc., a Delaware corporation headquartered in Nashville, Tennessee, and primarily addresses executive compensation program adoption and a Board of Directors retirement.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period. The document focuses exclusively on governance and compensation structures.
Material Changes and Governance Updates
- 2025 Executive Officer Performance Excellence Program (PEP): Adopted on February 18, 2025, this program ties executive cash awards to performance targets.
- Performance Weighting: Awards are weighted 80% on EBITDA targets and 20% on quality metrics (Healthcare-Associated Infections and Sepsis, Complication and Mortality, and Care Experience).
- Target Award Levels:
- Samuel N. Hazen (CEO): 175% of base salary.
- Michael A. Marks (CFO) and Jon M. Foster (COO): 125% of base salary.
- Payout Structure: EBITDA and quality portions range from 0% (below threshold) to 200% (maximum performance). A specific condition states that if actual EBITDA falls below 90% of the target, no payment is made for the quality-weighted portion.
- Board Retirement: Meg G. Crofton will retire from the Board of Directors effective at the annual meeting of stockholders on April 24, 2025.
Guidance, Risks, and Contingencies
The filing outlines specific contingencies regarding the Executive Officer PEP:
- Clawback Provisions: Awards are subject to mandatory repayment or adjustment if operating results are restated or if a participant's conduct materially disrupts the business.
- Discretionary Adjustments: The Compensation Committee retains the right to adjust targets or results for unusual events or changes in governmental definitions of quality metrics.
- Payment Form: All awards under this program are paid solely in cash.
Investor Verification Checklist
- Verify the specific EBITDA targets and quality metric definitions in the attached Exhibit 10.1 (2025 Executive Officer Performance Excellence Program).
- Confirm the impact of the 90% EBITDA threshold on potential quality metric payouts.
- Review the full terms of the clawback and repayment provisions for executive compensation.
- Monitor the April 24, 2025, annual meeting for the formal retirement of Meg G. Crofton and any potential Board composition changes.